Pfizer Inc.
Pfizer Inc. (PFE) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · PFE · as of Mar 31, 2025
Ownership Breakdown
3,055
Institutional Holders
▼ 77 vs Q4
$97.43B
Total Inst. Value
▼ $2.01B vs Q4
5.70B
Shares Outstanding
freeFloat 99.86%
3.76B
13F Shares Held
▲ 9.18M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
PFE largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC pharmaceutical preparations | 523.17M | 9.17% | 9.17% | $13.26T | May 9, 2025 | ▲ 4.63M |
BLACKROCK, INC. pharmaceutical preparations | 474.17M | 8.31% | 8.31% | $12.02T | May 2, 2025 | ▲ 22.43M |
STATE STREET CORP pharmaceutical preparations | 296.97M | 5.20% | 5.20% | $7.53T | May 15, 2025 | ▲ 6.49M |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 125.65M | 2.20% | 2.20% | $3.18T | May 13, 2025 | ▲ 5.06M |
WELLINGTON MANAGEMENT GROUP LLP pharmaceutical preparations | 103.49M | 1.81% | 1.81% | $2.62T | May 13, 2025 | ▼ 36.50M |
NORGES BANK pharmaceutical preparations | 86.05M | 1.51% | 1.51% | $2.18T | May 11, 2026 | ▼ 1.73M |
MORGAN STANLEY pharmaceutical preparations | 80.44M | 1.41% | 1.41% | $2.04T | May 15, 2025 | ▲ 6.54M |
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ pharmaceutical preparations | 75.45M | 1.32% | 1.32% | $1.91T | May 2, 2025 | ▼ 1.06M |
NORTHERN TRUST CORP pharmaceutical preparations | 62.33M | 1.09% | 1.09% | $1.58T | May 13, 2025 | ▲ 3.94M |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 56.07M | 98.26% | 98.26% | $1.42T | May 15, 2025 | ▲ 10.96M |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
29
Increased
+183.18M shares2
New Positions
first time holders17
Decreased
−179.57M shares0
Sold Out
fully exitedNet shares change (top 50)
+3.60M
+183.18M / −179.57M
Net new holders
+14
2 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
PFE insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
BOURLA ALBERT Chairman & CEO | May 29, 2026 | Award | 23 | — | — | 772.8K | Form 4 ↗ |
BOURLA ALBERT Chairman & CEO | May 15, 2026 | Award | 24 | — | — | 773.3K | Form 4 ↗ |
BOURLA ALBERT Chairman & CEO | Apr 30, 2026 | Award | 22 | — | — | 760.2K | Form 4 ↗ |
Gottlieb Scott director | Apr 23, 2026 | Award | 7,686.539 | — | — | 57.0K | Form 4 ↗ |
NORA JOHNSON SUZANNE M director | Apr 23, 2026 | Award | 7,686.539 | — | — | 117.0K | Form 4 ↗ |
LITTMAN DAN R. director | Apr 23, 2026 | Award | 7,686.539 | — | — | 74.5K | Form 4 ↗ |
BLAYLOCK RONALD E director | Apr 23, 2026 | Award | 7,686.539 | — | — | 84.0K | Form 4 ↗ |
Buckley Mortimer J director | Apr 23, 2026 | Award | 7,686.539 | — | — | 24.4K | Form 4 ↗ |
Desmond-Hellmann Susan director | Apr 23, 2026 | Award | 7,686.539 | — | — | 45.6K | Form 4 ↗ |
Echevarria Joseph director | Apr 23, 2026 | Award | 7,686.539 | — | — | 161.1K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Pfizer Inc. (PFE) is primarily owned by institutional investors, who hold approximately 66.0% of total shares outstanding. Company insiders own approximately 0.14%, while retail and public investors account for the remaining 33.91%.
The largest institutional shareholder of Pfizer Inc. is VANGUARD GROUP INC, holding approximately 523.17 million shares — equal to 9.17% of outstanding shares — as of March 31, 2025.
A total of 3,055 institutional investors currently hold PFE stock, with a combined institutional value of approximately $97.43 billion as of the most recent 13F filing period.
Frequently asked questions
PFE ownershipPfizer Inc. (PFE) is primarily owned by institutional investors, who hold approximately 66.0% of shares. The largest shareholder is VANGUARD GROUP INC with a 9.17% stake. Company insiders hold 0.14%. Data sourced from SEC Form 13F as of March 31, 2025.